UNSPSC 51413700: Vasodilator pyrrolidines

Vasodilator drugs made from tetrahydropyrroles.

UNSPSC 51413700 Vasodilator pyrrolidines is a Class code that encompasses emergency medications and pharmaceutical products used in acute care settings, particularly by emergency medical services and health system procurement offices. State and local governments solicit under this code for emergency pharmaceuticals including vasodilators, alpha-blockers, calcium channel blockers, and sympathomimetic agents—medications critical to advanced life support protocols. The issuing bodies span municipal fire and rescue departments, state health and human services agencies, and multi-state cooperative purchasing alliances coordinating procurement across member jurisdictions. Recent solicitations show city purchasing departments and state health agencies are the primary buyers, with cooperative purchasing organizations playing an intermediary role in aggregating demand across multiple states and local entities.

Recent activity appears in Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications—specifically Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—for Tampa Fire Rescue, with a $40,000 estimated contract value and a due date of April 8, 2026; the solicitation included a 5 percent Small Local Business Enterprise bid discount. The Texas Health and Human Services Commission released an RFI (HHS0017013) in early April 2026 exploring direct-to-manufacturer prescription programs, signaling potential future procurement restructuring but carrying no immediate contract value. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers nationwide, with contract terms of two years and optional extensions; this solicitation weighted price competitiveness at 75 percent and required vendors to maintain specific insurance minimums and comply with cGMP and DSCSA certification standards. Vendors should expect administrative fees at 3 percent and performance penalties ranging from $200 to $1,500 per violation in cooperative purchasing arrangements.